Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock, Par Value $0.001
Shares outstanding: 94,715,322
Number of holders: 62
Total 13F shares, excl. options: 72,174,486
Shares change: +675,986
Total reported value, excl. options: $918,052,641
Value change: -$7,807,548
Number of buys: 39
Number of sells: -34
Price: $12.72

Significant Holders of Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN) as of Q1 2022

82 filings reported holding ENFN - Enfusion Inc. - Common Stock, Par Value $0.001 as of Q1 2022.
Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 72,174,486 shares of 94,715,322 outstanding shares and own 76.2% of the company stock.
Largest 10 shareholders include FTV Management Company, L.P. (31,297,606 shares), ICONIQ Capital, LLC (14,039,594 shares), Dragoneer Investment Group, LLC (6,490,000 shares), HHLR ADVISORS, LTD. (4,975,183 shares), ALLIANCEBERNSTEIN L.P. (2,476,089 shares), Ararat Capital Management, LP (1,909,825 shares), VANGUARD GROUP INC (1,731,919 shares), TimesSquare Capital Management, LLC (1,631,305 shares), BlackRock Inc. (1,342,703 shares), and Bank of New York Mellon Corp (762,883 shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.